Clinical Trial Update: Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid [Phase 2]

View source ↗

Summary

Phase 2 trial update examining how platelet levels influence outcomes in glioblastoma patients treated with temozolomide.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Centre Henri Becquerel | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED